ClinicalTrials.Veeva

Menu

Cytokine Levels in Conversion Disorder

T

Trakya University

Status

Completed

Conditions

Conversion Disorder

Treatments

Other: conversion disorder

Study type

Observational

Funder types

Other

Identifiers

NCT00971360
TUTFEK 2009/173

Details and patient eligibility

About

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Alzheimer's Disease

Exclusion criteria

  • Autoimmune disease
  • Neurological disease
  • Any organic disorder that could possibly affect proinflammatory cytokines
  • Pregnancy
  • Any drug usage within 2 weeks
  • Any active or passive immunization within 6 months
  • Any other DSM-IV axis I psychiatric disorder
  • Mental retardation
  • Developmental disorder of childhood

Trial design

30 participants in 2 patient groups

Conversion disorder
Treatment:
Other: conversion disorder
Healthy control
Treatment:
Other: conversion disorder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems